Survival after resection of synchronous non–small cell lung cancer

Slides:

Advertisements

Similar presentations

Photodynamic Laser Therapy for Lesions in the Airway

Advertisements

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer

Impact of Race on Outcomes of Patients with Non-small Cell Lung Cancer

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

Local recurrence after surgery for non–small cell lung cancer: A recursive partitioning analysis of multi-institutional data Chris R. Kelsey, MD, Kristin.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Sotiris C. Stamou, MD, PhD, Michael Robich, MD, MSPH, Robert E

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Lung cancer screening: No more excuses

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

A risk factor paper on air leaks: Now it's time for treatment strategy papers from the only 5-tool hospital athlete—the thoracic surgeon Robert James.

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Interventional radiology suite or hybrid operating room: Which is the best for lung nodule localization? Robert B. Cameron, MD The Journal of Thoracic.

The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non–small cell lung cancer Kyong-Ah Yoon,

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Ground glass opacity of the lung: The veil that needs lifting

Circulating tumor DNA: Solid data from liquid biopsies

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

Benefits of resection for metachronous lung cancer

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial Stacey.

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S

Robert James Cerfolio, MD, FACS, FCCP, Ayesha S

Lobar and sublobar resection with and without brachytherapy for small stage IA non– small cell lung cancer Hiran C. Fernando, FRCS, FRCSEd, Ricardo S.

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Yang Zhang, MD, Haiquan Chen, MD, PhD

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Support Your Specialty

Fixing the supply problem

Bartley P. Griffith, MD, FACS, FRCS

Military surgeons just want to have fun

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

It’s All in the “Swerve of the Curve”

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

We are the company we keep: The importance of the tumor microenvironment Sai Yendamuri, MD, FACS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Who is your plastic surgeon

Robert James Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma Kimberly S. Grant, MD,

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

The patent internal thoracic artery graft: Increased degree of difficulty for left-sided pulmonary resections Robbin G. Cohen, MD, MMM The Journal of.

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

Pulmonary metastasectomy for suspected pancreaticobiliary cancer

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT) Neal E. Dunlap,

“The more things change…”: The challenges ahead

First in line for robotic surgery: Would you want to know?

Aritoshi Hattori, MD, Kenji Suzuki, MD

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Who should decide margin length in pulmonary excision of lung cancer?

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

The clinical stage of non–small cell lung cancer as assessed by means of fluorodeoxyglucose–positron emission tomographic/computed tomographic scanning.

Surveillance Epidemiology and End Results Evaluation of the Role of Surgery for Stage I Small Cell Lung Cancer James B. Yu, MD, Roy H. Decker, MD, PhD,

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Debunking dogma: The arduous task of writing AATS consensus guidelines

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Kristin A. Higgins, MD, Junzo P. Chino, MD, Neal Ready, MD, Mark W

Presentation transcript:

Survival after resection of synchronous non–small cell lung cancer Thomas Fabian, MD, FCCP, Ayesha S. Bryant, MSPH, MD, Angela L. Mouhlas, MD, John A. Federico, MD, Robert J. Cerfolio, MD, FACS, FCCP The Journal of Thoracic and Cardiovascular Surgery Volume 142, Issue 3, Pages 547-553 (September 2011) DOI: 10.1016/j.jtcvs.2011.03.035 Copyright © 2011 Terms and Conditions

Figure 1 Location of non–small cell lung cancer: A, all tumors; B, bilateral tumors. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 547-553DOI: (10.1016/j.jtcvs.2011.03.035) Copyright © 2011 Terms and Conditions

Figure 2 Kaplan-Meier survival curve depicting actual overall survival (N = 67) and 5-year survival (52%). Lighter lines indicate 95% confidence intervals. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 547-553DOI: (10.1016/j.jtcvs.2011.03.035) Copyright © 2011 Terms and Conditions

Figure 3 The Kaplan-Meier overall 5-year survival by side of resection and histologic type. The Journal of Thoracic and Cardiovascular Surgery 2011 142, 547-553DOI: (10.1016/j.jtcvs.2011.03.035) Copyright © 2011 Terms and Conditions